These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 16672373)

  • 1. Langerhans cells cross-present antigen derived from skin.
    Stoitzner P; Tripp CH; Eberhart A; Price KM; Jung JY; Bursch L; Ronchese F; Romani N
    Proc Natl Acad Sci U S A; 2006 May; 103(20):7783-8. PubMed ID: 16672373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keratinocytes function as accessory cells for presentation of endogenous antigen expressed in the epidermis.
    Kim BS; Miyagawa F; Cho YH; Bennett CL; Clausen BE; Katz SI
    J Invest Dermatol; 2009 Dec; 129(12):2805-17. PubMed ID: 19554018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of epidermal Langerhans cells with antigenic proteins: attempts to harness their properties for immunotherapy.
    Flacher V; Sparber F; Tripp CH; Romani N; Stoitzner P
    Cancer Immunol Immunother; 2009 Jul; 58(7):1137-47. PubMed ID: 18677477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen Uptake by Langerhans Cells Is Required for the Induction of Regulatory T Cells and the Acquisition of Tolerance During Epicutaneous Immunotherapy in OVA-Sensitized Mice.
    Dioszeghy V; Mondoulet L; Laoubi L; Dhelft V; Plaquet C; Bouzereau A; Dupont C; Sampson H
    Front Immunol; 2018; 9():1951. PubMed ID: 30233572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dendritic cells of mucosa and skin: "recruited for vaccination"].
    Le Borgne M; Dubois B; Kaiserlian D
    Med Sci (Paris); 2007 Oct; 23(10):819-25. PubMed ID: 17937889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine Langerin+ dermal dendritic cells prime CD8+ T cells while Langerhans cells induce cross-tolerance.
    Flacher V; Tripp CH; Mairhofer DG; Steinman RM; Stoitzner P; Idoyaga J; Romani N
    EMBO Mol Med; 2014 Sep; 6(9):1191-204. PubMed ID: 25085878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells in distinct oral mucosal tissues engage different mechanisms to prime CD8+ T cells.
    Nudel I; Elnekave M; Furmanov K; Arizon M; Clausen BE; Wilensky A; Hovav AH
    J Immunol; 2011 Jan; 186(2):891-900. PubMed ID: 21160044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD70-CD27 interaction augments CD8+ T-cell activation by human epidermal Langerhans cells.
    Polak ME; Newell L; Taraban VY; Pickard C; Healy E; Friedmann PS; Al-Shamkhani A; Ardern-Jones MR
    J Invest Dermatol; 2012 Jun; 132(6):1636-44. PubMed ID: 22377764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Langerhans cells prime IL-17-producing T cells and dampen genital cytotoxic responses following mucosal immunization.
    Hervouet C; Luci C; Rol N; Rousseau D; Kissenpfennig A; Malissen B; Czerkinsky C; Anjuère F
    J Immunol; 2010 May; 184(9):4842-51. PubMed ID: 20351191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha 6 integrins are required for Langerhans cell migration from the epidermis.
    Price AA; Cumberbatch M; Kimber I; Ager A
    J Exp Med; 1997 Nov; 186(10):1725-35. PubMed ID: 9362532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
    Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
    J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis.
    Ritter U; Meissner A; Scheidig C; Körner H
    Eur J Immunol; 2004 Jun; 34(6):1542-50. PubMed ID: 15162423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin.
    Sugita K; Kabashima K; Atarashi K; Shimauchi T; Kobayashi M; Tokura Y
    Clin Exp Immunol; 2007 Jan; 147(1):176-83. PubMed ID: 17177977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.
    Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM
    J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissolving microneedle delivery of nanoparticle-encapsulated antigen elicits efficient cross-priming and Th1 immune responses by murine Langerhans cells.
    Zaric M; Lyubomska O; Poux C; Hanna ML; McCrudden MT; Malissen B; Ingram RJ; Power UF; Scott CJ; Donnelly RF; Kissenpfennig A
    J Invest Dermatol; 2015 Feb; 135(2):425-434. PubMed ID: 25243789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal Langerhans cells rapidly capture and present antigens from C-type lectin-targeting antibodies deposited in the dermis.
    Flacher V; Tripp CH; Stoitzner P; Haid B; Ebner S; Del Frari B; Koch F; Park CG; Steinman RM; Idoyaga J; Romani N
    J Invest Dermatol; 2010 Mar; 130(3):755-62. PubMed ID: 19890348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Freshly isolated Langerhans cells negatively regulate naïve T cell activation in response to peptide antigen through cell-to-cell contact.
    Imai Y; Hayashi N; Yasuda K; Tsutsui H; Mizutani H; Nakanishi K
    J Dermatol Sci; 2008 Jul; 51(1):19-29. PubMed ID: 18367382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake and presentation of exogenous antigen and presentation of endogenously produced antigen by skin dendritic cells represent equivalent pathways for the priming of cellular immune responses following biolistic DNA immunization.
    Sudowe S; Dominitzki S; Montermann E; Bros M; Grabbe S; Reske-Kunz AB
    Immunology; 2009 Sep; 128(1 Suppl):e193-205. PubMed ID: 18800984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor immunotherapy by epicutaneous immunization requires langerhans cells.
    Stoitzner P; Green LK; Jung JY; Price KM; Tripp CH; Malissen B; Kissenpfennig A; Hermans IF; Ronchese F
    J Immunol; 2008 Feb; 180(3):1991-8. PubMed ID: 18209098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cutaneous immune system].
    Schmitt D
    C R Seances Soc Biol Fil; 1994; 188(3):207-21. PubMed ID: 7834504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.